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Neuro-inflammatory effects of 
photodegradative products of 
bilirubin
J. Jašprová1, M Dal Ben2,7, D. Hurný3, S. Hwang4, K. Žížalová1, J. Kotek  3, R. J. Wong5,  
D. K. Stevenson5, S. Gazzin2, C. Tiribelli2 & L. Vítek  1,6
Phototherapy was introduced in the early 1950’s, and is the primary treatment of severe neonatal 
jaundice or Crigler-Najjar syndrome. Nevertheless, the potential biological effects of the products 
generated from the photodegradation of bilirubin during phototherapy remain unknown. This is very 
relevant in light of recent clinical observations demonstrating that the use of aggressive phototherapy 
can increase morbidity or even mortality, in extremely low birthweight (ELBW) infants. The aim of our 
study was to investigate the effects of bilirubin, lumirubin (LR, its major photo-oxidative product), and 
BOX A and B (its monopyrrolic oxidative products) on the central nervous system (CNS) using in vitro 
and ex vivo experimental models. The effects of bilirubin photoproducts on cell viability and expression 
of selected genes were tested in human fibroblasts, three human CNS cell lines (neuroblastoma SH-
SY5Y, microglial HMC3, and glioblastoma U-87 cell lines), and organotypic rat hippocampal slices. 
Neither bilirubin nor its photo-oxidative products affected cell viability in any of our models. In contrast, 
LR in biologically-relevant concentrations (25 μM) significantly increased gene expression of several 
pro-inflammatory genes as well as production of TNF-α in organotypic rat hippocampal slices. These 
findings might underlie the adverse outcomes observed in ELBW infants undergoing aggressive 
phototherapy.
Since its discovery in the early 1950’s1, phototherapy (PT) has been used as the primary treatment of neonatal 
hyperbilirubinemia. Possible adverse effects of PT include the bronze baby syndrome, water loss, damage to 
unprotected eyes2, and/or hypocalcemia3. Quite surprisingly, recent studies suggest that PT might also be associ-
ated with increased risk of ileus4, allergic diseases5, type 1 diabetes6, cancer7–9, and even mortality10,11, especially 
in extremely low birthweight (ELBW) neonates.
Photochemical reactions of bilirubin occurring during light exposure lead to the formation of more polar 
bilirubin photoderivatives, thereby enhancing the elimination of bilirubin elimination12,13. Although these photo-
degradative products are generally regarded as being benign2, potential undesirable biological effects have never 
been properly investigated. During PT, unconjugated bilirubin (UCB) is converted into photoisomers (PIs), Z,E- 
and E,Z-bilirubins and lumirubin (LR) (Fig. 1a)14; and photo-oxidative products (monopyrrolic, dipyrrolic, and/
or tripyrrolic) (Fig. 1b)15,16. Whether the PT light itself, bilirubin, or the photo-products formed from bilirubin 
during PT may cause adverse effects remains unclear.
To this end, we investigated the effects of UCB, LR (its major photoproduct), and the monopyrrolic bilirubin 
oxidative products, BOX A and BOX B, on cell viability as well as on the expression of several pro-inflammatory 
and oxidative stress-related genes by using in vitro and ex vivo experimental models.
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Results
The effect of bilirubin photo-oxidative products on cell viability. We recently demonstrated that 
short-term exposures of a mixture of bilirubin PIs to human neuroblastoma SH-SY5Y cells did not affect cell via-
bility, but modulated the expression of genes involved in cell cycle regulation17. In this current study, we extended 
these preliminary findings by investigating the effects of UCB, LR, BOX A, and BOX B exposures on the viability 
of fibroblasts, several neuronal cell types, and organotypic rat hippocampal slices.
To assess the recently reported biological impact of BOXes18, we first assessed cell viability of normal human 
skin fibroblasts and glucose-6-phosphate dehydrogenase (G6PD)-deficient fibroblasts (known to be sensitive to 
oxidative stress19) after exposure to various concentrations of BOX A or BOX B for 4 h to mimic the early phase 
Figure 1. (a) Bilirubin and bilirubin PIs. (A) Z,Z-Bilirubin IXα; (B) Z,E-Bilirubin IXα; (C) E,Z-Bilirubin IXα; 
(D) Z-Lumirubin Ixα. (b) Bilirubin oxidation products. Monopyrrolic: (A) BOX A, (B) BOX B; Dipyrrolic: 
(C,D) Propentdyopents; Tripyrrolic: (E) Biopyrrin a, (F) Biopyrrin b.
µmol/L
Normal Fibroblasts G6PD-Deficient Fibroblasts
BOX A BOX B BOX A BOX B
10 94.1 ± 6.4% 91.8 ± 3.8% 92.7 ± 2.2% 105.2 ± 4.1%
50 89.9 ± 4.3% 86.5 ± 5.7% 101.2 ± 10.0% 101.8 ± 4.7%
100 90.1 ± 2.9% 86.8 ± 1.4% 101.8 ± 6.9% 101.7 ± 4.2%
200 90.0 ± 5.2% 88.8 ± 3.3% 104.6 ± 8.8% 98.8 ± 1.5%
Table 1. Viability of human skin fibroblasts and G6PD-deficient fibroblasts exposed to BOX A and BOX B for 4 h.
www.nature.com/scientificreports/
3Scientific RepoRTs |  (2018) 8:7444  | DOI:10.1038/s41598-018-25684-2
of PT. We found that cell viability was not affected in either normal or G6PD-deficient fibroblast (Table 1) even at 
BOX concentrations far exceeding physiologic levels (up to 200 μmol/L).
Based on these findings, we then investigated the effects of bilirubin photo-oxidative products on cell viability 
in vitro using three central nervous system (CNS) models: (1) SH-SY5Y cells, a human neuroblastoma line, which 
has been used for studying neuronal metabolism; (2) U-87 cells, a human glioblastoma line, which resemble 
astrocytes; and (3) HMC3 cells, a human microglial line, which are resident CNS macrophages. For all cell lines, 
exposures to UCB, LR, BOX A, or BOX B for 4 h did not affect cell viability even at the relatively high concentra-
tion used (25 μmol/L) (Table 2).
To see if these in vitro effects on individual cell lines correlate in vivo, we then performed similar exposure 
studies using organotypic rat hippocampal slices, which is more representative of the complex physiologic mul-
ticellular environment since it preserves intercellular interactions within a maintained extracellular matrix20. 
This model has been used to study the pathogenesis of neurodegenerative diseases and of potential neurotoxic 
effects by various compounds21. Similar to our in vitro studies, the viability of organotypic rat hippocampal slices 
was unchanged compared with controls after 4-h exposures to UCB, LR, BOX A, or BOX B using an MTT assay 
(Fig. 2A). In addition, no difference in lactate dehydrogenase (LDH) release (a marker of cell damage or death) 
was observed (Fig. 2B). Furthermore, cell apoptosis, measured by Hoechst staining22, was also not significantly 
Cell line Ctrl UCB LR BOX A BOX B
SH-SY5Y 100 ± 2.2% 93.0 ± 3.4% 109.3 ± 9.8% 108.9 ± 9.7% 105.3 ± 9.0%
HMC3 100 ± 0.8% 90.5 ± 5.8%* 104.0 ± 4.0% 101.3 ± 6.5% 101.2 ± 3.6%
U-87 100 ± 1.0% 103.8 ± 10.6% 119.6 ± 9.7%* 114.5 ± 15.1% 107.4 ± 12.4%
Table 2. Viability of human CNS cell lines exposed to UCB, LR, BOX A and BOX B for 4 h. Cell viability was 
evaluated by MTT assay. Concentration of tested compounds = 25 μmol/L. Ctrl, control; UCB, unconjugated 
bilirubin; LR, lumirubin. *p < 0.05 vs. Ctrl.
Figure 2. Viability of organotypic rat hippocampal slices after 4 h of exposure to UCB, LR, BOX A, or BOX 
B. Cell viability was evaluated by MTT assay (A), LDH release (B), HOECHST staining (C), and glutamate 
release (D). The values acquired for control cells were used to define 100% level. Concentrations of tested 
compounds = 25 μmol/L.
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different (Fig. 2C). After exposure to UCB, the increase in glutamate release (a marker of excitotoxicity, Fig. 2D) 
was marginal; whereas, no effects were observed after exposure to LR, BOX A, or BOX B (Fig. 2D). Collectively, 
all viability studies demonstrated that a short-term exposure to UCB and its photo-oxidative products did not 
lead to cell damage or apoptosis.
The effect of bilirubin photo-oxidative products on expression of heme oxygenase-1. The 
expression of heme oxygenase-1 (HMOX1), a marker of oxidative stress23 and the key enzyme in the heme cat-
abolic pathway, was not affected in any of human CNS cell lines (data not shown) following a 4-h exposure to 
any of the studied compounds. In contrast, HMOX1 expression was significantly upregulated in organotypic rat 
hippocampal slices incubated for 4 h with UCB or BOX A (2.5- and 2-fold, respectively, p < 0.05), but not with 
LR or BOX B (Fig. 3).
The effect of bilirubin photo-oxidative products on the expression of pro-inflammatory genes 
in CNS models. Since UCB was demonstrated to have pro-inflammatory effects on neurons24, astrocytes25, 
and microglia26, we then analyzed the expression levels of the major pro-inflammatory genes.
LR consistently increased the expression of all studied pro-inflammatory genes, TNF-α, IL-1β, IL-6, and 
cyclooxygenase-2 (COX-2), while the effects of other bile pigments were either negligible (BOX A) or mild (BOX B) 
(Fig. 4). Differences were apparent in all CNS cell lines, but were greater in organotypic rat hippocampal slices, 
with highly significant changes in the expression of all studied pro-inflammatory genes after LR exposure (Fig. 4). 
Increase in pro-inflammatory gene expression was observed for UCB (mostly on SH-SY5Y cells and organotypic 
rat hippocampal slices) (Fig. 4), but dramatic changes were observed only after LR exposure to all cell lines and 
organotypic rat hippocampal slices. In fact, the expression of TNF-α, IL-1β, IL-6, and COX-2 in organotypic rat 
hippocampal slices exposed to LR increased from 15- (COX-2) to 400-fold (IL-6) (Fig. 4).
The effect of bilirubin photo-oxidative products on the production of TNF-α in organotypic 
rat hippocampal slices. To confirm that overexpression of pro-inflammatory genes was mediated at the 
translational level, we evaluated the production of TNF-α in organotypic rat hippocampal slices. Although UCB 
had virtually no effect, BOX A and BOX B slightly (albeit not significantly) increased TNF-α concentration in the 
media. However, LR exposure led to a dramatic increase in TNF-α production (2423 vs. 16 ng/L, p < 0.01, Fig. 5).
Discussion
Although millions of infants have been treated with PT for over the last five decades, recent clinical data suggest 
that PT might not be entirely harmless4–11, particularly in ELBW neonates, in whom increased morbidity as well 
as mortality has recently been reported. However, mechanistic studies on this subject are limited.
Here, we report that the major bilirubin photo-oxidative products (LR, BOX A, and BOX B) do not affect cell 
viability in any of the studied lines as well as in slices of rat hippocampus, the most vulnerable region affected in 
severe hyperbilirubinemia22.
In these studies, we focused mainly on the early phase of PT represented by a 4 h exposure of cells and tissues 
to bilirubin photodegradative products. In this early time period, plasma UCB concentrations are high and begin 
to decrease as LR concentrations, initially almost non-existent, start to increase. It can be inferred that LR con-
centrations vary between 25 to 50 µmol/L, with a decrease in plasma UCB concentrations to 30% during PT, and 
that no more than 20% of bilirubin PIs are Z,E-bilirubin27.
During this short-term exposure, neither LR nor bilirubin oxidative products (BOX A and B) caused any 
decreases in cell viability, even in G6PD-deficient fibroblasts, which have been shown to be very sensitive to oxi-
dative stress. The gene expression of HMOX1/Hmox1, an important oxidative stress-response gene, was also only 
negligibly upregulated after exposure to LR, BOX A, or BOX B. Based on these observations, we concluded that 
Figure 3. Expression of Hmox1 mRNA in organotypic rat hippocampal slices after 4 h exposure to UCB, 
LR, BOX A, or BOX B. Expression of Hmox1 in control organotypic rat hippocampal slices was set to 100%. 
Concentrations of tested compounds = 25 μmol/L.
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bilirubin photo-oxidative products in biologically-relevant concentrations (25 µmol/L) present at the early stage 
of PT have no major effects on both cell viability and on the induction of oxidative stress. This is an important 
observation not only for LR, but also for BOX A and BOX B, which have been recently proposed to have an impor-
tant pathophysiological role18. Moreover, our findings are consistent with the early studies by Silberberg et al. 
who did not detect any toxic effects of photo-irradiated bilirubin on myelinating cerebellum cultures28.
In contrast to our viability findings, we found a significant effect of LR on the expression of the major 
pro-inflammatory genes. It is noteworthy that PT given to hyperbilirubinemic neonates has been shown to be 
Figure 4. mRNA expressions of pro-inflammatory genes in CNS cells (A,C,E,G) and organotypic rat 
hippocampal slices (B,D,F,H). Four h exposure to UCB, LR, BOX A, or BOX B (25 μmol/L). Controls expressed 
as 100%. SH-SY5Y, human neuroblastoma cell line; U-87, human glioblastoma cells; HMC3, human microglia.
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associated with possible lymphocyte genotoxicity29, increased concentrations of eosinophilic cationic protein30, 
as well as with an overall risk of childhood allergic diseases5. It is still not known whether these observations 
are due to a direct effect of PT light or to bilirubin photoderivatives generated during PT. Bilirubin per se is a 
well-recognized immunosuppressant31, although UCB has also been reported to induce, under specific condi-
tions, the production of pro-inflammatory cytokines in astrocytes as well as in microglia26,32. However, no data 
has been reported that shows any immunomodulatory effects of bilirubin photo-oxidative products.
In our studies, we observed that after a short-term exposure to LR, there is a striking upregulation of 
pro-inflammatory genes (TNF-α, IL-1β, and IL-6), which encode major inflammatory cytokines that play crucial 
and multiple roles in the CNS33, including neurodevelopment with possible clinical implications such as impair-
ment of neurogenesis34, development of childhood-onset mood disorders35, or major depressive disorders36. In 
fact, pro-inflammatory cytokine levels have been reported to increase over 100-fold over normal under patholog-
ical brain conditions – and indeed, we also show the same increase in TNF-α levels in media of organotypic rat 
hippocampal slices exposed to LR. Numerous studies have also reported that pro-inflammatory cytokines exert 
harmful effects on neurogenesis34. Upregulation of pro-inflammatory IL-1β, IL-6, and TNF-α triggers additional 
pathways, such as COX-237, which is also implicated neuro-inflammation and neurogenesis38, although COX-2 
seems to have an opposite effect compared to pro-inflammatory cytokines. The upregulation of COX-2 observed 
in our study might represent a feedback mechanism that is invoked to compensate for impaired (e.g. neuroge-
netic) signaling pathways38.
To further elucidate the specific mechanistic pathways involved in neuro-inflammation and exposure to pho-
todegradative products of bilirubin, a more detailed investigation into the impact of PT on the inflammasome 
should be performed, and should also include in vivo studies to verify the clinical relevance of our data.
In conclusion, our data in context with reported roles of inflammatory cytokines collectively point to a pos-
sible explanation of the recently-reported potentially harmful effects of PT in small premature neonates4–11. In 
fact, LR seems to be more pro-inflammatory than the neurotoxic concentrations of unbound UCB (140 nM). 
Importantly, our results agree with the clinical data by Kurt et al.39, who reported an increase in systemic con-
centrations of circulating pro-inflammatory cytokines in hyperbilirubinemic newborn infants treated with PT, 
suggesting the translational relevance of our findings. Thus, the use of specific anti-inflammatory regimens initi-
ated during intensive PT should be considered as a viable approach to reducing the adverse effects of PT in ELBW 
neonates.
Methods
Chemicals. Bilirubin (Sigma-Aldrich, St. Louis, MO, USA) was purified before use according to McDonagh 
and Assisi40. Methanol was purchased from Merck (Darmstadt, Germany), and ammonium acetate (NH4OAc) 
from Penta (Czech Republic). All other chemicals were purchased from Sigma.
Preparation of bilirubin PIs. Pure bilirubin photo-derivatives were prepared as previously described41. 
Briefly, UCB (24 mg) was dissolved in 1 mL of 0.1 M NaOH and mixed with 1.2 g of rabbit serum albumin in PBS 
to a total volume of 50 mL. The solution was transferred to glass non-heparinized capillary tubes and exposed to 
30 min of photo-irradiation using a Lilly photo-therapeutic device (TSE, Czech Republic), composed of an array 
of light-emitting diodes (LEDs) with a peak of 464 nm and wavelength range of 430–500 nm with an irradiance 
of 70 μW/cm2/nm corresponding to the total intensity of 2.2 mW/cm2. Each 5 mL of photo-irradiated sample 
was then precipitated with 25 mL of 0.1 M NH4OAc in CH3OH and centrifuged. The supernatant was evaporated 
under vacuum and the residue was dissolved in the mixture CHCl3:CH3OH (9:1, v/v) with a trace of TFA (20 µL) 
and then evaporated under vacuum again. Because of the light sensitivity of UCB and its PIs, all procedures were 
carried out under dim light and in aluminium-wrapped flasks. Evaporation was performed under vacuum and a 
stream of nitrogen.
Figure 5. The effect of LR and other bilirubin photo-oxidative products on TNF-α production by organotypic 
rat hippocampal slices. Four h exposure to UCB, LR, BOX A, or BOX B (25 μmol/L). Controls expressed as 
100%.
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Thin layer chromatography. The residue after the latter evaporation was dissolved in a small amount of 
CHCl3:CH3OH:TFA mixture, and separated by thin layer chromatography (TLC) [200 × 200 × 0.25 mm Kieselgel 
60 TLC plates (Merck, Darmstadt, Germany); mobile phase = chloroform:methanol:water, 40:9:1, v/v/v]. The upper 
yellow band was the residual bilirubin, the second yellow band was LR as verified by LC/MS17. LR was scraped out 
from the TLC plate, extracted with pure CH3OH from silicagel, and evaporated under a stream of N2. Evaporated 
LR was stored at −20 °C until use.
Preparation of BOXes. The total synthesis of (Z)-2-(3-ethenyl-4-methyl-5-oxo-1,5-dihydro-2H-pyrrol-
2-lidene) ethanamide (Z-BOX A) and (Z)-2-(4-ethenyl-3-methyl-5-oxo-1,5-dihydro-2H-pyrrol-2-ylidene) 
ethanamide (Z-BOX B) was prepared performed using a method reported previously42. TLC was performed 
on silica gel sheets (Merck TLC aluminium sheets silica gel 60 F254) and column chromatography on silica gel 
(60–230 mesh, Merck). NMR spectra were recorded on a VNMRS300, VarianUNITY INOVA 400 or Bruker 
Avance III 600 spectrometers, using 5-mm sample tubes. Internal references for 1H NMR: CDCl3: TMS (δ = 0.00); 
D2O: t-BuOH (δ = 1.25); DMSO: DMSO (δ = 2.50); 13C NMR: CDCl3: CDCl3 (δ = 77.0); D2O: t-BuOH (δ = 32.8); 
DMSO: DMSO (δ = 39.52). LR-MS (ESI) spectra were recorded on a Bruker Esquire 3000 with an ion-trap detec-
tor in positive or negative modes.
Purification by column chromatography (silica gel; chloroform/methanol 1:5, v/v) and crystallization from 
methanol yielded BOX A and BOX B, respectively, with spectral data were in accordance to those previously 
reported42.
Cell line studies. In vitro studies were performed on three different human neuronal cell types (SH-SY5Y, 
U-87, and HMC3, ATCC, Manassas, VA, USA) and two types of fibroblasts [human dermal fibroblast cell line 
(No. C00425PA, Thermo Fisher Scientific, NJ, USA); and G6PD-deficient fibroblast cell line (GM01163 from 
15-yr-old male) from Coriell Institute for Medical Research, Camden, NJ, USA]. Human SH-SY5Y cells were 
cultured in a mixture of MEM Eagle and Ham’s F12 media (1:1, v/v), containing 15% fetal bovine serum (FBS); 
human U-87 cells were cultured in DMEM containing 10% FBS, human HMC3 cells were maintained in MEM 
with 10% FBS; both types of fibroblasts were cultured in MEM with 15% FBS. All lines were maintained at 
37 °C, in a 5% CO2 atmosphere. For functional tests, cells were seeded at a concentration of 50,000 cells/cm2. 
Authentication of cell lines was confirmed by an independent laboratory (Generi Biotech, Czech Republic).
Organotypic rat hippocampal slice preparation. Wistar Han™ rats, at 8 (P8) days after birth (P: post-
natal age in days), were obtained from the animal facility of the University of Trieste (Italy). Animal experiments 
were performed according to the Italian Law (decree 87–848) and European Community directive (86-606-ECC). 
The study was approved by the Animal Care and Use Committee of the University of Trieste along with regular 
communication with the competent Italian Ministry. The maximal effort was used to minimize the number of the 
animals used and their sufferance was done, in the respect of the 3R rule.
Organotypic rat hippocampal slices were prepared as previously described22. Immediately after sacrifice by 
decapitation, the hippocampus was harvested and maintained in dissection medium (ice cold Gey’s Balanced Salt 
Solution plus D-Glucose 10 mg/mL) until use. A McIIwain tissue chopper (Gomshall Surrey, UK) was used to 
cut transverse 350-μm slices. Healthy slices, selected for structural integrity under stereomicroscope inspection, 
were maintained in dissection medium for 60 min to allow clearing of cutting surfaces from preparation proce-
dure stress. Slices were then transferred to a sterile, semi-porous Millicell-CM inserts (PICM03050, Millipore, 
Darmstadt, Germany), grown in 1 mL of medium, and maintained at 37 °C, 5% CO2, 95% humidity in a humid-
ified incubator. The medium was changed the day after cutting and every two days thereafter. Slices were main-
tained in culture 5 days before starting treatment.
Treatment. Fibroblasts were treated for 4 h with BOX A or BOX B in concentrations of 10, 50, 100, and 
200 μmol/L containing DMSO corresponding to its concentration used for dissolving BOXes. SH-SY5Y, U-87, 
and HMC3 cells were treated with UCB, LR, BOX A, or BOX B in concentrations of 25 μmol/L for 4 h for both, 
viability and gene expression studies. Organotypic rat hippocampal slices were treated for 4 h with 25 μmol/L of 
UCB (corresponding to toxic concentration of 140 nmol/L of free bilirubin, Bf, based on our previous in vitro 
studies43–46), LR, and BOX A or BOX B starting after 5 days. The concentration of UCB dissolved in DMSO 
required to reach the desired Bf in the medium was quantified according to Roca et al.47. Control organotypic rat 
hippocampal slices were exposed to the same final concentration of DMSO used to dissolve the UCB.
Cell viability analyses. The viability of fibroblasts was measured using a Cell-Counting Kit-8 (CCK-8, 
Dojindo Laboratories, MD, USA), utilizing WST-8 [2-(2- methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disul-
fophenyl)-2H-tetrazolium salt], according to manufacturer’s instructions. After 4 h of incubation with CCK-8 solu-
tion, the absorbance was read at 450 nm. Results were expressed as percentage compared to the control cells (100%).
Mitochondrial activity. Mitochondrial metabolic activity was assessed using a 1-(4, 5-dimethyltiazol-2-yl)-3, 
5-diphenylformazan (MTT) assay (Sigma-Aldrich). For post-challenge experiments, slices for each biological 
repetition were incubated with 0.5 mg/mL of MTT in medium at 37 °C for 1 h, harvested, and the precipitated 
salt dissolved in DMSO. Absorbance was detected at 562 nm using a LD 400 C luminescence detector (Beckman 
coulter, Milan, Italy). Results were expressed as percentage of activity related to the control (100%).
Lactate dehydrogenase release. The amount of total extracellular LDH in medium, indicative of membrane 
leakage, was determined using a CytoTox-ONE™ Homogeneous Membrane Integrity Assay (G7891, Promega, 
Madison, WI, USA). After treatment, the supernatant was collected and the reaction was carried out according 
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to manufacturer’s instructions. The fluorescence (560 Ex/590 Em) was determined using an EnSpire Multimode 
Plate Reader (PerkinElmer, Waltham, MA, USA), and the background fluorescence subtracted. LDH in chal-
lenged slices was expressed as fold change compared to the control slices.
Hoechst staining. Evidence of chromatin condensation, a marker of cell death by apoptosis, was obtained by 
administration of 1 μg/mL Hoechst 33258 (Sigma-Aldrich). Slices challenged with UCB, LR, BOX A, BOX B, or 
DMSO alone were fixed for 30 min at room temperature in 3% paraformaldehyde. Apoptotic cells were counted 
at 40× magnification, by fluorescence microscopy using a Leica DM2000 (Leica Mycrosystems Srl, Solms, 
Germany) by three separate individuals. At least three different fields were analyzed in each biological repetition. 
Results were expressed as percentage of apoptotic cells related to the total number (apoptotic plus unaffected) 
cells in the control (100%).
Glutamate release. The concentration of extracellular glutamate, a marker of bilirubin-induced excitotoxicity, 
was quantified using a Glutamate Assay Kit (MAK004, Sigma-Aldrich). Briefly, after the treatment, the super-
natant was collected, and the assay was performed according to manufacturer’s instructions. The absorbance 
(450 nm), proportional to the glutamate present, was determined using an EnSpire Multimode Plate Reader 
(PerkinElmer). Glutamate release in challenged-slice medium was expressed as fold change compared to the 
control slices.
Quantitative real-time PCR. mRNA expression of genes of interest was analyzed by quantitative RT-PCR. 
Total RNA was extracted using TRI Reagent® RNA Isolation Reagent (Sigma-Aldrich) and GenUP Total RNA 
Kit (BiotechRabbit, Heningsdorf, Germany) from organotypic rat hippocampal slices or human cell lines, respec-
tively, following the manufacturer’s instructions. Complementary DNA (cDNA) was synthesized with the High 
Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Foster City, CA, USA). For the quantitative 
RT-PCR in organotypic rat hippocampal slices, primers were designed using the Beacon designer 4.2 software 
(Premier Biosoft International, Palo Alto, CA, USA) on rat sequences available in GenBank (Table 3). The reac-
tion was performed in a final volume of 15 μL in an iQ5 Bio-Rad Thermal cycler (Bio-Rad Laboratories, Hercules, 
CA, USA). Briefly, 25 ng of cDNA and the corresponding gene-specific sense/antisense primers (250 nmol/L each, 
with the exception of Cox2 and Il1β, 500 and 750 nM, respectively) were diluted in the Sso Advance SYBER green 
supermix (Bio-Rad Laboratories). Amplification of target genes was accomplished using the following protocol: 
3 min at 95 °C, 40 cycles at 95 °C for 20 sec, 60 °C for 20 sec, and 72 °C for 30 sec. Specificity of the amplification 
was verified by a melting-curve analysis, and non-specific products of PCR were not found in any case. The 
relative quantification was made using the iCycleriQ software, version 3.1 (Bio-Rad Laboratories) by the ΔΔCt 
method, taking into account the efficiencies of the individual genes and normalizing the results to the housekeep-
ing genes (Hprt, Gapdh)48,49.
RT-PCR of genes in human cell lines was performed on ViiA 7 instrument (Applied Biosystems) in 12-μL 
reaction volumes, containing 5 μL of 10-fold diluted cDNA template from a completed reverse transcription reac-
tion, 1x SYBR Green Master Mix (Applied Biosystems), and 200–1000 nmol/L of forward and reverse primers. 
Data were normalized to HPRT1 level and expressed in percentage to control. Primers of human genes used for 
RT-PCR analyses are given in Table 4.
Gene Forward Reverse
Hmox1 GGTGATGGCCTCCTTGTA ATAGACTGGGTTCTGCTTGT
Il-1β AACAAGATAGAAGTCAAGA ATGGTGAAGTCAACTATG
Il-6 TCCTTCCTACCCCAACTTCCAATG CCACAGTGAGGAATGTCCACAAAC
Tnf-α CAACTACGATGCTCAGAAACAC AGACAGCCTGATCCACTCC
Cox-2 CTTTCAATGTGCAAGACC TACTGTAGGGTTAATGTCATC
Hprt1 AGACTGAAGAGCTACTGTAATGAC GGCTGTACTGCTTGACCAAG
Gapdh CTCTCTGCTCCTCCCTGTTC CACCGACCTTCACCATCTTG
Table 3. List of rodent genes used for gene expression analyses. Hprt1 and Gapdh were used as the 
housekeeping genes.
Gene Forward Reverse
HMOX1 atgccccaggatttgtca cccttctgaaagttcctcat
IL-1β acgatgcacctgtacgatca ggaccagacatcaccaagct
IL-6 aggcactggcagaaaacaac agctctggcttgttcctcac
TNF-α acctcctctctgccatcaaga ggaagacccctcccagataga
COX-2 ggtggagaagtgggttttca acagcccttcacgttattgc
HPRT1 acatctggagtcctattgacatcg ccgcccaaagggaactgatag
Table 4. List of human genes used for gene expression analyses. HPRT1 was used as the housekeeping gene.
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Determination of TNF-α production. Determination of TNF-α concentrations in media of organotypic 
rat hippocampal slices exposed to UCB and bilirubin photo-oxidative products was measured using an ELISA test 
according to manufacturer’s instructions (ab100785, Abcam, Cambridge, UK). At the end of the treatments, cul-
tures media were collected and stored at −80 °C until use. Briefly, media were incubated overnight at 4 °C degree 
in the plate coated with the primary antibody against TNF-α. Subsequently, the samples were incubated with 
biotinylated antibody and streptavidin-HRP solution. The reaction was started by adding the TMB solution for 
30 minutes and then stopped by adding the Stop Solution. The absorbance (450 nm), proportional to the TNF-α 
present, was determined using an EnSpire Multimode Plate Reader (PerkinElmer). The range of TNF-α detection 
was 80–20,000 pg/mL, the sensitivity less than 25 pg/mL.
Statistical analyses. Data are expressed as mean ± SD. Differences between variables were evaluated by the 
Mann-Whitney Rank Sum test. Differences were considered statistically significant at p < 0.05. Statistical analyses 
were performed using Prism 6 software (GraphPad, San Diego, CA, USA).
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